The new advisor is also the founder of WiseHS medical and Pharmaceutical consulting, a European business and clinical consultancy that offers guidance to the medical cannabis industry.
Vancouver-based EXMceuticals engaged WiseHS to help the firm get its cannabis R&D license for its Portuguese laboratory, CEO Jonathan Summers told shareholders.
“(Dr Castro Alves) engagement will clearly assist the future development of EXMceuticals in Portugal,” Summers said. “He and EXM share a common goal to establish Portugal as a centre for medical cannabis healthcare and science.”
A medical doctor by background, Castro Alves completed general surgery training in the US and obtained the degree of instructor in advanced trauma life support in Illinois. In Europe, he led Portuguese health regulator Infarmed’s board of directors and assisted numerous medical non-profits.
EXMceuticals appointed Castro Alves in observance of the regime governing the exercise of functions by political officers and senior public officeholders in Portugal, according to the firm.
Summers said that the next step in the company’s strategy is to have a licensed and operating high-quality ingredients factory that will produce to medical standards and have many industrial applications.
EXMceuticals also said that chief strategy officer Marc Bernier was stepping down from the role to move to a consultancy relationship. Bernier was appointed to the company’s board of directors and granted options to purchase 1.5 million shares at C$2 for a ten-year period from the date of grant.
Contact Angela at [email protected]proactiveinvestors.com
Follow her on Twitter @AHarmantas